National Paediatric Diabetes Audit

The contract will initially be delivered for NHS-funded care in England, Wales, and publicly funded care in Jersey for a period of 3 years, at a maximum total budget of up to PS1,071,920 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years.

The maximum budget 'core' value is PS1,071,920 GBP excluding VAT. This excludes the potential two year extension and aspirational intent which will be included in the service specification at point of tender. The role of a national clinical audit is to stimulate healthcare improvement through the provision of high quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information.

Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and there is a shared understanding of what good care looks like. The overarching aim is to stimulate improvements in care for children and young people (CYP) with paediatric diabetes who receive care from Paediatric Diabetes Units (PDUs), by measuring variations in quality, experience and outcomes of NHS care in England and Wales, and publicly funded care in Jersey.

During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement. *The term CYP (Children and Young People) will be used throughout this notice to refer to children, adolescents and young people up to 24 years (treated within a Paediatric Diabetes Unit (PDU)). This audit programme is expected to: a. Develop a robust, high quality audit designed around key quality indicators likely to best support local and national quality improvement; b.

Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate; c. Enable improvements through the provision of timely, high quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, commissioner, MDT, possibly consultant or clinical team level and other levels of reporting; d .Engage parents, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit; e. Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract; f.

Ensure robust methodological and statistical input at all stages of the audit; g. Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly; h. Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data; i.

Utilise strong and effective project and programme management to deliver audit outputs on time and within budget; and j. develop and maintain strong engagement with local clinicians, networks, commissioners, parents and their families and carers and charity and community support groups in order to drive improvements in services for babies. Further details of the existing audit can be found at: rcpch.ac.uk/work-we-do/clinical-audits/npda For more information about this opportunity, please visit the Delta eSourcing portal at: delta-esourcing.com/tenders/UK-UK-London:-Health-services... To respond to this opportunity, please click here: delta-esourcing.com/respond/B249J9GYMY